| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |